Header cover image
  • Investing Ideas
  • South Korean Transformative Artificial intelligence (AI) Healthcare Stocks

South Korean Transformative Artificial intelligence (AI) Healthcare Stocks

Results

12

1 new

Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.

12 companies

SEERS

Market Cap: ₩1.1t

Engages in the development, manufacturing, and sales of medical devices in South Korea.

A458870

₩29,500.00

7D

1.4%

1Y

345.8%

GC Genome

Market Cap: ₩126.1b

Operates as a clinical genome analysis company in South Korea.

New

A340450

₩5,330.00

7D

-1.3%

1Y

-45.7%

Parataxis Korea

Market Cap: ₩44.1b

A clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide.

A288330

₩416.00

7D

0%

1Y

-40.1%

CarelabsLtd

Market Cap: ₩38.2b

Operates as a healthcare and beauty care platform company in South Korea.

A263700

₩1,967.00

7D

1.8%

1Y

-40.1%

GENINUS

Market Cap: ₩94.9b

A bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia.

A389030

₩2,825.00

7D

-13.7%

1Y

23.6%

DRTECH

Market Cap: ₩106.3b

Develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally.

A214680

₩1,273.00

7D

-4.1%

1Y

-33.7%

JLK

Market Cap: ₩132.3b

Provides diagnosis support to the patients with its AI-driven medical platform in South Korea.

A322510

₩5,210.00

7D

24.6%

1Y

-11.1%

INFINITT Healthcare

Market Cap: ₩186.0b

Engages in medical imaging information solution software business.

A071200

₩7,630.00

7D

4.7%

1Y

3.5%

Pharos iBio

Market Cap: ₩77.8b

Engages in the development of treatments for rare and refractory diseases using AI based drug development platform in South Korea.

A388870

₩6,010.00

7D

-23.1%

1Y

-10.7%

SG HealthCare

Market Cap: ₩257.8b

Provides medical diagnostic equipment.

A398120

₩2,360.00

7D

-6.9%

1Y

-38.7%

Lunit

Market Cap: ₩1.1t

Provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea.

A328130

₩14,760.00

7D

0.4%

1Y

-34.9%

NanoEntek

Market Cap: ₩172.9b

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

A039860

₩4,540.00

7D

1.6%

1Y

24.0%